BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 309 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $39,876,000 | -42.2% | 336,306 | -32.8% | 4.16% | -47.6% |
| Q4 2021 | $68,956,000 | +35.9% | 500,373 | +36.9% | 7.93% | +28.4% |
| Q3 2021 | $50,754,000 | +30.4% | 365,373 | -8.9% | 6.18% | +36.9% |
| Q2 2021 | $38,930,000 | -33.8% | 401,006 | -53.4% | 4.51% | -24.9% |
| Q1 2021 | $58,799,000 | -50.3% | 860,261 | -37.7% | 6.01% | -53.1% |
| Q4 2020 | $118,303,000 | +38.9% | 1,380,261 | +5.3% | 12.80% | +33.8% |
| Q3 2020 | $85,180,000 | -16.9% | 1,310,261 | -6.6% | 9.56% | +2.5% |
| Q2 2020 | $102,519,000 | +106.0% | 1,402,261 | -4.1% | 9.33% | +2.3% |
| Q1 2020 | $49,778,000 | -27.3% | 1,462,761 | +16.3% | 9.11% | -11.7% |
| Q4 2019 | $68,486,000 | +30.6% | 1,258,020 | +0.1% | 10.32% | +66.5% |
| Q3 2019 | $52,433,000 | +19.6% | 1,256,774 | +25.5% | 6.19% | +43.7% |
| Q2 2019 | $43,852,000 | -9.8% | 1,001,410 | +6.1% | 4.31% | -33.6% |
| Q1 2019 | $48,601,000 | +95.9% | 944,266 | +40.8% | 6.50% | +73.7% |
| Q4 2018 | $24,804,000 | +6.1% | 670,738 | +7.8% | 3.74% | +129.5% |
| Q3 2018 | $23,368,000 | -1.1% | 622,328 | +4.1% | 1.63% | -1.1% |
| Q2 2018 | $23,617,000 | +77.8% | 597,596 | +15.9% | 1.65% | +57.0% |
| Q1 2018 | $13,285,000 | – | 515,737 | – | 1.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 490,422 | $12,755,876 | 13.24% |
| FNY Investment Advisers, LLC | 30 | $0 | 0.00% |